ORIDIS Biomed (A) is a biopharmaceutical company focusing on the discovery and development of targeted treatment solutions against liver diseases. Building on its proprietary TISSOMICS™ research engine and decades of experience in the area of the liver, ORIDIS Biomed has developed an attractive therapeutic portfolio and has successfully commercialized the technology in R&D partnerships with Blue Chip players such as Boehriner Ingelheim, Roche and Medarex.
ORIDIS BIOMED Forschungs- und Entwicklungs GmbH
Elisabethstraße 84 / 1.OG
A-8010 Graz
Reisnerstrasse 40/3
A-1030 Vienna
Tel.: +43 (1) 513 10 72
Fax: +43 (1) 513 10 72-200
office@gamma-capital.com
www.gamma-capital.com